Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 5,144,000 | 1,774,000 | 4,128,000 | 5,275,000 | 3,433,000 |
| Depreciation Amortization | 836,000 | 786,000 | 897,000 | 1,150,000 | 1,272,000 |
| Accounts receivable | -1,076,000 | -172,000 | 681,000 | 223,000 | -498,000 |
| Accounts payable and accrued liabilities | 1,503,000 | -193,000 | -426,000 | -731,000 | 1,497,000 |
| Other Working Capital | 993,000 | -354,000 | 692,000 | -555,000 | 706,000 |
| Other Operating Activity | 135,000 | 1,708,000 | 295,000 | 983,000 | -163,000 |
| Operating Cash Flow | $7,535,000 | $3,549,000 | $6,267,000 | $6,345,000 | $6,247,000 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -532,000 | -612,000 | -491,000 | -333,000 | -356,000 |
| Net Acquisitions | -12,452,000 | -622,000 | -405,000 | -688,000 | -273,000 |
| Purchase Of Investment | -851,000 | -1,169,000 | -930,000 | -2,550,000 | -1,943,000 |
| Sale Of Investment | 899,000 | 1,477,000 | 2,705,000 | 1,153,000 | 1,255,000 |
| Other Investing Activity | 0 | 0 | 0 | 0 | 1,870,000 |
| Investing Cash Flow | $-12,936,000 | $-926,000 | $879,000 | $-2,418,000 | $553,000 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | -19,000 | 12,000 | -601,000 | 1,000,000 | 0 |
| Debt Issued | 20,660,000 | 0 | N/A | 14,586,000 | 0 |
| Debt Repayment | -4,018,000 | -17,000 | N/A | N/A | N/A |
| Common Stock Issued | 155,000 | 232,000 | 347,000 | 0 | 0 |
| Common Stock Repurchased | -7,586,000 | -665,000 | -320,000 | 0 | 0 |
| Dividend Paid | -3,294,000 | -2,661,000 | -2,555,000 | N/A | N/A |
| Other Financing Activity | -146,000 | -194,000 | -313,000 | -13,655,000 | -6,783,000 |
| Financing Cash Flow | $5,752,000 | $-3,293,000 | $-3,442,000 | $1,931,000 | $-6,783,000 |
| Exchange Rate Effect | -300,000 | -577,000 | -10,000 | 16,000 | 0 |
| Beginning Cash Position | 8,348,000 | 9,595,000 | 5,901,000 | 27,000 | 10,000 |
| End Cash Position | 8,399,000 | 8,348,000 | 9,595,000 | 5,901,000 | 27,000 |
| Net Cash Flow | $51,000 | $-1,247,000 | $3,694,000 | $5,874,000 | $17,000 |
| Free Cash Flow | |||||
| Operating Cash Flow | 7,535,000 | 3,549,000 | 6,267,000 | 6,345,000 | 6,247,000 |
| Capital Expenditure | -532,000 | -612,000 | -491,000 | -333,000 | -356,000 |
| Free Cash Flow | 7,003,000 | 2,937,000 | 5,776,000 | 6,012,000 | 5,891,000 |